Effects Of Long-term Vitamin E Supplementation On Cardiovascular Events And Cancer: A Randomized Controlled Trial

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 3994
Sex Both Genders
Age Range 45-64, 65+
Body Types Overweight
Notes for this study:
In a three year extension of the HOPE trial which gave persons over the age of 55 (preexisting diabetes or cardiovascular ailments) supplementation of 400 IU vitamin E, there appeared to be an increase in heart failure rates relative to placebo associated with a greater rate of decline in LVEF. Despite the increase in heart failure, overall cardiovascular mortality was not changed.

No benefit nor harm was noted for cancers in this study.

Full details on all 2 studies are available to Examine Plus members.

Already a member? Login now to access.